Hasleton Mark Daniel 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Feb 28, 2019
Insider Transaction Report
Form 4
Hasleton Mark Daniel
VP Business Development
Transactions
- Award
Stock Option (right to buy)
2019-02-26+22,500→ 22,500 totalExercise: $3.16Exp: 2029-02-26→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The Stock Option will vest in 4 equal installments of 5,625 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022.